Please login to the form below

Not currently logged in
Email:
Password:

Defitelio

This page shows the latest Defitelio news and features for those working in and with pharma, biotech and healthcare.

Jazz Pharma bags FDA approval for rare disease drug

Jazz Pharma bags FDA approval for rare disease drug

Defitelio given the green light to treat patients who develop severe hepatic VOD. ... Jazz acquired Defitelio as part of its $1bn purchase of Italy's Gentium in 2013.

Latest news

  • SMC: Celgene's Abraxane 'too expensive' for Scotland SMC: Celgene's Abraxane 'too expensive' for Scotland

    But medicines watchdog backs Sovaldi, Invokana, Defitelio, Relvar Ellipta. Pancreatic cancer patients in Scotland should not have NHS access to Celgene's Abraxane, according to guidance from the Scottish Medicines Consortium ... Drugs that received

  • Jazz offers $1bn for Italy's Gentium Jazz offers $1bn for Italy's Gentium

    The drug was approved in Europe in October, despite suggestions - voiced by Gentium itself earlier this year - that concerns about Defitelio's benefit:risk profile might delay registration. ... 10m. Gentium also has a small business unit selling active

  • Gentium expects EMA rejection for defibrotide Gentium expects EMA rejection for defibrotide

    Negative feedback for drug’s use in liver condition associated with stem cell transplantation

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics